Published in BMJ on August 28, 1993
Neurocysticercosis in an Orthodox Jewish community in New York City. N Engl J Med (1992) 3.86
The incidence and lifetime prevalence of neurological disorders in a prospective community-based study in the UK. Brain (2000) 4.76
Mortality from epilepsy: results from a prospective population-based study. Lancet (1994) 4.31
Vigabatrin and behaviour disturbances. Lancet (1990) 3.30
Remission of epilepsy: results from the National General Practice Study of Epilepsy. Lancet (1995) 3.17
Epilepsy in a population of 6000 re-examined: secular trends in first attendance rates, prevalence, and prognosis. J Neurol Neurosurg Psychiatry (1995) 2.84
Drowning in people with epilepsy: how great is the risk? Neurology (2008) 2.80
National General Practice Study of Epilepsy: recurrence after a first seizure. Lancet (1990) 2.65
Comprehensive primary health care antiepileptic drug treatment programme in rural and semi-urban Kenya. ICBERG (International Community-based Epilepsy Research Group) Lancet (1991) 2.36
Neurocysticercosis and epilepsy in developing countries. J Neurol Neurosurg Psychiatry (2000) 2.28
Incidence and prevalence studies in epilepsy and their methodological problems: a review. J Neurol Neurosurg Psychiatry (1987) 2.25
Case-control study of SUDEP. Neurology (2005) 2.11
The treatment gap in epilepsy: the current situation and ways forward. Epilepsia (2001) 2.10
The treatment of epilepsy in developing countries: where do we go from here? Bull World Health Organ (2003) 2.00
Periventricular heterotopia: phenotypic heterogeneity and correlation with Filamin A mutations. Brain (2006) 2.00
Validation of a screening questionnaire for the detection of epileptic seizures in epidemiological studies. Brain (1992) 1.94
Apnoea and bradycardia during epileptic seizures: relation to sudden death in epilepsy. J Neurol Neurosurg Psychiatry (1996) 1.89
Efficacy assessment of phenobarbital in epilepsy: a large community-based intervention trial in rural China. Lancet Neurol (2006) 1.83
Effects of topiramate on cognitive function. J Neurol Neurosurg Psychiatry (2000) 1.81
The psychiatric comorbidity of epilepsy. Acta Neurol Scand (2004) 1.77
Causes of death among people with convulsive epilepsy in rural West China: a prospective study. Neurology (2011) 1.77
Sudden unexpected deaths in epilepsy--where are we now? Seizure (1996) 1.73
Long-term use of lamotrigine and vigabatrin in severe refractory epilepsy: audit of outcome. BMJ (1996) 1.70
Incidence of epilepsy: a systematic review and meta-analysis. Neurology (2011) 1.68
The prevalence and treatment gap in epilepsy in China: an ILAE/IBE/WHO study. Neurology (2003) 1.66
Mortality in patients with epilepsy: a study of patients in long term residential care. J Neurol Neurosurg Psychiatry (1993) 1.64
From patterns to processes: phase and density dependencies in the Canadian lynx cycle. Proc Natl Acad Sci U S A (1998) 1.59
Incidence of sudden unexpected death in an adult outpatient cohort with epilepsy at a tertiary referral centre. J Neurol Neurosurg Psychiatry (1995) 1.58
Epilepsy: getting the diagnosis right. BMJ (1997) 1.56
Mortality in epilepsy in the first 11 to 14 years after diagnosis: multivariate analysis of a long-term, prospective, population-based cohort. Ann Neurol (2001) 1.56
Clinical features of convulsive status epilepticus: a study of 220 cases in western China. Eur J Neurol (2009) 1.53
Prognostic factors affecting long-term retention of topiramate in patients with chronic epilepsy. Epilepsia (2000) 1.52
The natural history of epilepsy: an epidemiological view. J Neurol Neurosurg Psychiatry (2004) 1.51
Sudden unexpected death in epilepsy: a series of witnessed deaths. J Neurol Neurosurg Psychiatry (2000) 1.48
The cost of epilepsy in the United Kingdom: an estimation based on the results of two population-based studies. Epilepsy Res (1994) 1.44
Rhys-davies exsanguinator: a haven for bacteria. J Hand Surg Eur Vol (2007) 1.43
Carbamazepine in comparative trials: pharmacokinetic characteristics too often forgotten. Neurology (1999) 1.41
The risk of cross-infection when marking surgical patients prior to surgery - review of two types of marking pens. Ann R Coll Surg Engl (2007) 1.39
Minimally invasive craniopuncture therapy vs. conservative treatment for spontaneous intracerebral hemorrhage: results from a randomized clinical trial in China. Int J Stroke (2009) 1.24
Sudden death in epilepsy: a study of incidence in a young cohort with epilepsy and learning difficulty. Epilepsia (1995) 1.24
Epileptic seizures in an Andean region of Ecuador. Incidence and prevalence and regional variation. Brain (1992) 1.22
Circumstances of death in sudden death in epilepsy: interviews of bereaved relatives. J Neurol Neurosurg Psychiatry (1998) 1.21
The National General Practice Study of Epilepsy. The syndromic classification of the International League Against Epilepsy applied to epilepsy in a general population. Arch Neurol (1992) 1.16
National General Practice Study of Epilepsy and Epileptic Seizures: objectives and study methodology of the largest reported prospective cohort study of epilepsy. National General Practice Study of Epilepsy and Epileptic Seizures (NGPSE). Neuroepidemiology (1989) 1.15
National General Practice Study of Epilepsy (NGPSE): partial seizure patterns in a general population. Neurology (1992) 1.15
Prognosis of epilepsy: a review and further analysis of the first nine years of the British National General Practice Study of Epilepsy, a prospective population-based study. Epilepsia (1997) 1.14
Penicillin-resistant pneumococci in a Merseyside hospital. J Hosp Infect (1991) 1.11
The epidemiology of epilepsy: the size of the problem. Seizure (2001) 1.10
A crossover, add-on trial of talampanel in patients with refractory partial seizures. Neurology (2002) 1.10
Reducing mortality: an important aim of epilepsy management. J Neurol Neurosurg Psychiatry (2004) 1.09
Antiepileptic drug treatment in a community health care setting in northern Ecuador: a prospective 12-month assessment. Epilepsy Res (1993) 1.08
Factors influencing the incidence of lamotrigine-related skin rash. Ann Pharmacother (1999) 1.08
Do alterations in inter-ictal heart rate variability predict sudden unexpected death in epilepsy? Epilepsy Res (2009) 1.07
Complex partial status. Neurology (1996) 1.06
Severe persistent visual field constriction associated with vigabatrin. Reaction might be dose dependent. BMJ (1997) 1.03
The characteristics of epilepsy in a largely untreated population in rural Ecuador. J Neurol Neurosurg Psychiatry (1994) 1.03
Neurotransmitter secretion along growing nerve processes: comparison with synaptic vesicle exocytosis. J Cell Biol (1999) 1.02
The National Hospital Seizure Severity Scale: a further development of the Chalfont Seizure Severity Scale. Epilepsia (1996) 1.02
Long-term retention rates of lamotrigine, gabapentin, and topiramate in chronic epilepsy. Epilepsia (2000) 1.00
A large-scale study of epilepsy in Ecuador: methodological aspects. Neuroepidemiology (1992) 0.99
A comparative pharmacokinetic study of intravenous and intramuscular midazolam in patients with epilepsy. Epilepsy Res (1992) 0.99
Factors predicting prognosis of epilepsy after presentation with seizures. Ann Neurol (2000) 0.98
The effect of oral flumazenil on interictal epileptic activity: results of a double-blind, placebo-controlled study. Epilepsy Res (1993) 0.97
The excitatory amino acid antagonist D-CPP-ene (SDZ EAA-494) in patients with epilepsy. Epilepsy Res (1993) 0.96
A longitudinal quantitative MRI study of community-based patients with chronic epilepsy and newly diagnosed seizures: methodology and preliminary findings. Neuroimage (2001) 0.96
Seizure aggravation in idiopathic generalized epilepsies. Epilepsia (2005) 0.96
Combined treatment with serine protease inhibitor aprotinin and matrix metalloproteinase inhibitor Batimastat (BB-94) does not prevent invasion of human esophageal and ovarian carcinoma cells in vivo. Anticancer Res (2000) 0.95
Long-term risk of developing epilepsy after febrile seizures: a prospective cohort study. Neurology (2012) 0.95
The epidemiology of epilepsy and learning disability. Epilepsia (2001) 0.95
Is the incidence of epilepsy falling in the UK? Lancet (1993) 0.94
Levels of stigmatization of patients with previously untreated epilepsy in northern Ecuador. Neuroepidemiology (1995) 0.91
Microdysgenesis with abnormal cortical myelinated fibres in temporal lobe epilepsy: a histopathological study with calbindin D-28-K immunohistochemistry. Neuropathol Appl Neurobiol (2000) 0.91
Complex partial status epilepticus: a recurrent problem. J Neurol Neurosurg Psychiatry (1994) 0.91
Metabolic activity of probiotics-oxalate degradation. Vet Microbiol (2008) 0.90
Colonization of butchers with livestock-associated methicillin-resistant Staphylococcus aureus. Zoonoses Public Health (2012) 0.90
Surgical treatment of patients with single and dual pathology: relevance of lesion and of hippocampal atrophy to seizure outcome. Neurology (1997) 0.90
The subjective handicap of epilepsy. A new approach to measuring treatment outcome. Brain (1998) 0.90
Neurological disease in a defined population: the results of a pilot study in two general practices. Neuroepidemiology (1996) 0.89
Rotavirus survival and stability in foods as determined by an optimised plaque assay procedure. Int J Food Microbiol (2000) 0.88
Neuroepidemiology in the United Kingdom. J Neurol Neurosurg Psychiatry (1993) 0.88
The impact of new antiepileptic drugs on the prognosis of epilepsy: seizure freedom should be the ultimate goal. Neurology (1996) 0.88
Premature mortality in refractory partial epilepsy: does surgical treatment make a difference? J Neurol Neurosurg Psychiatry (2010) 0.87
Developments in antiepileptic drug therapy. Curr Opin Neurol (1994) 0.86
First seizures associated with playing electronic screen games: a community-based study in Great Britain. Ann Neurol (1995) 0.86
Incidence of photosensitive epilepsy: a prospective national study. Electroencephalogr Clin Neurophysiol (1995) 0.85
Allergic skin rash with lamotrigine and concomitant valproate therapy: evidence for an increased risk. Arq Neuropsiquiatr (1996) 0.85
Headache and epilepsy. Curr Pain Headache Rep (2013) 0.85
Difficulties in extrapolating from clinical trial data to clinical practice: the case of antiepileptic drugs. Neurology (1997) 0.84
Help-seeking strategies for epilepsy by previously untreated patients in northern Ecuador. Epilepsy Res (1992) 0.84
Febrile convulsions in 220 children--neurological sequelae at 12 years follow-up. Eur Neurol (1999) 0.84
Sudden unexpected death in epilepsy. Postgrad Med J (1999) 0.84
Assessing the psychosocial consequences of epilepsy: a community-based study. Br J Gen Pract (1999) 0.84
A comprehensive community epilepsy programme: the Nakuru project. Epilepsy Res (1991) 0.84
Are qacG, qacH and qacJ genes transferring from food isolates to carriage isolates of staphylococci? J Hosp Infect (2011) 0.83
Research in epilepsy: development priorities for developing nations. Epilepsia (2003) 0.83
Ictal ECG changes in temporal lobe epilepsy. Arq Neuropsiquiatr (1995) 0.83
Presence of antiseptic resistance genes in porcine methicillin-resistant Staphylococcus aureus. Vet Microbiol (2012) 0.83
The epidemiology of epilepsy: the size of the problem. Seizure (2002) 0.83
The mortality associated with epilepsy, with particular reference to sudden unexpected death: a review. Epilepsia (1997) 0.83
Anticysticercal treatment and seizures in neurocysticercosis. Lancet Neurol (2004) 0.82
Change in stroke incidence from a population-based intervention trial in three urban communities in China. Neuroepidemiology (2007) 0.82